PL411078A1 - Complex silver compound, method for producing a complex compound and application of a complex compound - Google Patents
Complex silver compound, method for producing a complex compound and application of a complex compoundInfo
- Publication number
- PL411078A1 PL411078A1 PL411078A PL41107815A PL411078A1 PL 411078 A1 PL411078 A1 PL 411078A1 PL 411078 A PL411078 A PL 411078A PL 41107815 A PL41107815 A PL 41107815A PL 411078 A1 PL411078 A1 PL 411078A1
- Authority
- PL
- Poland
- Prior art keywords
- compound
- complex
- silver
- metronidazole
- producing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 229940100890 silver compound Drugs 0.000 title abstract 2
- 150000003379 silver compounds Chemical class 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 abstract 4
- 229960000282 metronidazole Drugs 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 239000000376 reactant Substances 0.000 abstract 2
- 239000012429 reaction media Substances 0.000 abstract 2
- 229910052709 silver Inorganic materials 0.000 abstract 2
- 239000004332 silver Substances 0.000 abstract 2
- -1 silver (I) compound Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 244000000010 microbial pathogen Species 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pest Control & Pesticides (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Wynalazek dotyczy związku kompleksowego srebra i metronidazolu, sposobu wytwarzania tego związku, oraz zastosowania związku do wytwarzania preparatu do hamowania rozwoju mikroorganizmów chorobotwórczych, w profilaktyce lub leczeniu zwierzęcia lub człowieka. W sposobie wytwarzania związku kompleksowego srebra i metronidazolu, stosuje się jako reagenty metronidazol i związek srebra(I), który to związek srebra(I) jest co najmniej częściowo rozpuszczalny w środowisku reakcyjnym. Reagenty zestawia się w środowisku reakcyjnym zawierającym rozpuszczalnik hydroksylowy w temperaturze 5 - 90°C, i prowadzi się reakcję przez 1 - 180 minut utrzymując temperaturę 5 - 90°C ewentualnie pobudzając mechanicznie środowisko reakcyjne, a następnie wydziela się związek kompleksowy srebra i metronidazolu.The invention relates to a complex compound of silver and metronidazole, a method for preparing this compound, and the use of a compound for the preparation of a preparation for inhibiting the development of pathogenic microorganisms, in the prevention or treatment of an animal or human. In the process for producing the silver compound and metronidazole, metronidazole and a silver (I) compound are used as reactants, which silver (I) compound is at least partially soluble in the reaction medium. The reactants are combined in a reaction medium containing a hydroxyl solvent at a temperature of 5 - 90 ° C, and the reaction is carried out for 1 - 180 minutes, maintaining the temperature at 5 - 90 ° C, optionally mechanically stimulating the reaction environment, and then the silver and metronidazole complex compound is isolated.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL411078A PL411078A1 (en) | 2015-01-27 | 2015-01-27 | Complex silver compound, method for producing a complex compound and application of a complex compound |
| PCT/EP2016/051710 WO2016120332A1 (en) | 2015-01-27 | 2016-01-27 | Silver complex compound, the method of preparation of the complex compound and the use of the complex compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL411078A PL411078A1 (en) | 2015-01-27 | 2015-01-27 | Complex silver compound, method for producing a complex compound and application of a complex compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL411078A1 true PL411078A1 (en) | 2016-08-01 |
Family
ID=55236377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL411078A PL411078A1 (en) | 2015-01-27 | 2015-01-27 | Complex silver compound, method for producing a complex compound and application of a complex compound |
Country Status (2)
| Country | Link |
|---|---|
| PL (1) | PL411078A1 (en) |
| WO (1) | WO2016120332A1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607159D0 (en) * | 1986-03-22 | 1986-04-30 | Smith & Nephew Ass | Pharmaceutical composition |
| US5744151A (en) * | 1995-06-30 | 1998-04-28 | Capelli; Christopher C. | Silver-based pharmaceutical compositions |
| CA2263473C (en) * | 1996-08-16 | 2003-04-22 | Christopher C. Capelli | Silver-based antimicrobial compositions |
| US6093414A (en) * | 1997-08-11 | 2000-07-25 | Christopher C. Capelli | Silver-based antimicrobial compositions |
| CN102688258A (en) * | 2012-06-16 | 2012-09-26 | 李泽红 | Medicine for external use for treating psoriasis, leucoderma, fungus infection and bromhidrosis |
| PL404583A1 (en) * | 2013-07-08 | 2015-01-19 | Uniwersytet Medyczny w Łodzi | A silver complex compound, a method for producing the compound, and the use of the compound |
-
2015
- 2015-01-27 PL PL411078A patent/PL411078A1/en unknown
-
2016
- 2016-01-27 WO PCT/EP2016/051710 patent/WO2016120332A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016120332A1 (en) | 2016-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020550901A1 (en) | Macrocyclic compounds for treating disease | |
| BR112017019287A2 (en) | compound, pharmaceutically acceptable composition, cancer treatment method, process for preparing the compound of formula I, method for treating cancer, and kit | |
| MX2020000387A (en) | General and direct method for preparing oligonucleotide-functiona lized metal-organic framework nanoparticles. | |
| MX2022014914A (en) | Glycan-interacting compounds and methods of use. | |
| PH12018502497A1 (en) | Adenosine derivatives for use in the treatment of cancer | |
| EP4635568A3 (en) | Compounds, salts thereof and methods for treatment of diseases | |
| PH12019500214A1 (en) | Substituted thiazolo-pyridine compounds as malt1 inhibitors | |
| MX2017016325A (en) | Brk inhibitory compound. | |
| EP3778605A3 (en) | Lrrk2 inhibitors and methods of making and using the same | |
| CY1124387T1 (en) | METHOD FOR PRODUCING A NEW NITROGEN-CONTAINING CHEMICAL COMPOUND OR SALT THEREOF, AND PRODUCING AN INTERMEDIATE THEREOF | |
| MX2020006237A (en) | Compounds for treatment of diseases related to dux4 expression. | |
| EA201790085A1 (en) | INHIBITORS OF LYSINE-SPECIFIC DEMETILASE-1 | |
| EP4183806A3 (en) | Glycan-interacting compounds and methods of use | |
| MX2018002344A (en) | Method for treating cancer. | |
| PH12021550382A1 (en) | Tetrahydropyridopyrimidine derivatives as ahr modulators | |
| MX378509B (en) | PYRIMIDINE COMPOUND AND ITS PHARMACEUTICAL USE. | |
| PH12018502314A1 (en) | Enhancer of zeste homolog 2 inhibitors | |
| PH12021550269A1 (en) | Heteroaromatic compounds as vanin inhibitors | |
| PH12018502337A1 (en) | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions | |
| JOP20210128A1 (en) | Heteroaromatic compounds as vanin inhibitors | |
| HK1252245A1 (en) | Nucleotides for the treatment of cancer | |
| MY195169A (en) | Cyclic Ether Derivatives of Pyrazolo[1,5-A]Pyrimidine-3-Carboxyamide | |
| EA201992196A1 (en) | METHOD FOR SYNTHESIS OF ZEOLITE CRYSTALS WITH AN EXTENDING AGENT | |
| UA117524C2 (en) | Plant stimulators, use thereof and method of plant stimulation | |
| PL411078A1 (en) | Complex silver compound, method for producing a complex compound and application of a complex compound |